Clinical studies recruiting near Guangdong

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NA · Second Affiliated Hospital, Zhejiang University, School of M · NCT04078230 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Pfizer · NCT05020236 Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
Phase 2 · Sun Yat-sen University · NCT05011487 Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 cfMSC Therapy for Diabetes
Phase 1/Phase 2 · Shenzhen Geno-Immune Medical Institute · NCT07495956 Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
Phase 1 · Second Affiliated Hospital of Guangzhou Medical University · NCT04952272 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · Colorado Prevention Center · NCT06024746 ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Phase 1/Phase 2 · Sun Yat-sen University · NCT07012954 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853 Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma
Phase N/A · Third Affiliated Hospital, Sun Yat-Sen University · NCT05991856 Electro-Acupuncture in Lung cancER : EALER Study
NA · Guangzhou University of Traditional Chinese Medicine · NCT07337096 NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
Phase 1 · Shenzhen Geno-Immune Medical Institute · NCT05262673 H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
Phase 1/Phase 2 · Shenzhen Geno-Immune Medical Institute · NCT07501156 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559 IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Phase 3 · Sun Yat-sen University · NCT05941741 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
Phase 3 · Sun Yat-sen University · NCT04136886 Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NA · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07126470 A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Huabo Biopharm Co., Ltd. · NCT06592274 Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in
Phase 4 · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06520397 Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI
NA · Nanfang Hospital, Southern Medical University · NCT05545605 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Bristol-Myers Squibb · NCT06929273 Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Phase 2 · Zhen-Hai Lu · NCT05228431 Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Phase 2 · Tongji Hospital · NCT06289062 CAR-T Immunotherapy Targeting CD19- ALL
Phase 1/Phase 2 · Shenzhen Geno-Immune Medical Institute · NCT04016129 Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Phase 2/Phase 3 · Sun Yat-sen University · NCT06280495 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
Phase 2 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT07028268

Look up another city

Look up another condition